Missouri State Highway Patrol to Evaluate CDEX Illicit Drug Detector; CDEX to Supply Three Units as Part of Pilot Test and Field Evaluation Program
ROCKVILLE, Md., Aug 30, 2006 (BUSINESS WIRE) -- CDEX Inc. (CEXI
9:30am 08/30/2006
CEXI announced today that it has received notification to proceed with the Missouri State Highway Patrol to conduct a Pilot Test and Field Evaluation Program. Under the program, CDEX will provide three of its Illicit Drug Detector prototypes for evaluation by the Missouri State Highway Patrol. The units will be evaluated for their effectiveness and efficacy in detecting trace amounts of methamphetamine. CDEX anticipates that the Pilot Test and Evaluation Program will be concluded by the end of 2006.
About CDEX Inc.
CDEX Inc. is a technology development company with a current focus on developing and marketing products using chemical detection and validation technologies. At present, CDEX is devoting its resources to two distinct areas: (i) and quality assurance (e.g., validation of prescription medication and detection of counterfeit or sub-par products for brand protection). ValiMed is one line of CDEX products for the healthcare market; and (ii) identification of substances of concern (e.g., illegal drugs for law enforcement in the homeland security market) CDEX is headquartered in Rockville, Maryland with its research and development laboratory in Tucson, Arizona. For more information, visit www.cdex-inc.com.
Any statements made in this press release which contain information that is not historical are essentially forward-looking. Many forward-looking statements can be identified by the use of words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks are detailed from time-to-time in filings with the Securities and Exchange Commission. There is no obligation to publicly update any forward-looking statements.
SOURCE: CDEX Inc.
CDEX Inc. Jerry Blair, 301-881-0080 jblair@cdex-inc.com |
